According to the company, the Vitros 5600 integrated system is designed to integrate clinical chemistry and immunoassay testing to increase laboratory productivity and will be able to perform more than 100 different chemistry, immunoassay and infectious disease assays on a single, high-quality system.
In addition to its current broad menu including user-defined applications, the Vitros 5600 integrated system will have the capability to run future tests for earlier detection of diseases. Commercial availability is expected in the fourth quarter of 2008.
Ortho Clinical Diagnostics is pursuing a worldwide registration program for the Vitros 5600 integrated system. The system has been registered for distribution by the Pharmaceutical and Medical Device Agency in Japan.
Mark Straley, worldwide commercial president of Ortho Clinical Diagnostics, said: “The Vitros 5600 integrated system will consolidate and simplify testing and proves you do not have to compromise quality to gain efficiency. By incorporating the flexibility to accommodate novel clinical diagnostic tests, this system has the potential to help doctors diagnose disease earlier and make better informed treatment decisions for patients.”